1. Home
  2. NLSP vs TSI Comparison

NLSP vs TSI Comparison

Compare NLSP & TSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • TSI
  • Stock Information
  • Founded
  • NLSP 2015
  • TSI 1987
  • Country
  • NLSP Switzerland
  • TSI United States
  • Employees
  • NLSP N/A
  • TSI N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • TSI Investment Managers
  • Sector
  • NLSP Health Care
  • TSI Finance
  • Exchange
  • NLSP Nasdaq
  • TSI Nasdaq
  • Market Cap
  • NLSP 243.8M
  • TSI 244.7M
  • IPO Year
  • NLSP 2021
  • TSI N/A
  • Fundamental
  • Price
  • NLSP $5.28
  • TSI $5.02
  • Analyst Decision
  • NLSP
  • TSI
  • Analyst Count
  • NLSP 0
  • TSI 0
  • Target Price
  • NLSP N/A
  • TSI N/A
  • AVG Volume (30 Days)
  • NLSP 26.9K
  • TSI 106.8K
  • Earning Date
  • NLSP 10-18-2024
  • TSI 01-01-0001
  • Dividend Yield
  • NLSP N/A
  • TSI 7.46%
  • EPS Growth
  • NLSP N/A
  • TSI N/A
  • EPS
  • NLSP N/A
  • TSI N/A
  • Revenue
  • NLSP N/A
  • TSI N/A
  • Revenue This Year
  • NLSP N/A
  • TSI N/A
  • Revenue Next Year
  • NLSP N/A
  • TSI N/A
  • P/E Ratio
  • NLSP N/A
  • TSI N/A
  • Revenue Growth
  • NLSP N/A
  • TSI N/A
  • 52 Week Low
  • NLSP $4.08
  • TSI $4.48
  • 52 Week High
  • NLSP $40.60
  • TSI $4.87
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 45.46
  • TSI 37.51
  • Support Level
  • NLSP $4.72
  • TSI $5.05
  • Resistance Level
  • NLSP $5.50
  • TSI $5.10
  • Average True Range (ATR)
  • NLSP 0.64
  • TSI 0.06
  • MACD
  • NLSP 0.05
  • TSI -0.02
  • Stochastic Oscillator
  • NLSP 41.67
  • TSI 10.53

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About TSI TCW Strategic Income Fund Inc.

Tcw Strategic Income Fund Inc operates as a closed-end management investment company. Its investment objective is to seek a total return comprised of current income and capital appreciation by investing in a wide range of securities. The company invests in a range of industries, such as airlines, banks, beverages, biotechnology, chemicals, computers, diversified financial services, entertainment, and others.

Share on Social Networks: